Patients with type 2 diabetes were on treatment with diabetic medications consisting of (combination of) insulin, metformin, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide 1 receptor agonist, sulfonylureas, and thiazolidinediones. This evidence concerns the gene INS and type 2 diabetes mellitus.